Skip to main content
Clinical Trials/NCT02196454
NCT02196454
Completed
N/A

Educating Pre/Teens and Their Parents on the Importance of HPV Vaccination

Children's Hospital of Philadelphia2 sites in 1 country110 target enrollmentJuly 2014

Overview

Phase
N/A
Intervention
Not specified
Conditions
Vaccine Acceptance
Sponsor
Children's Hospital of Philadelphia
Enrollment
110
Locations
2
Primary Endpoint
HPV Vaccine Series Initiation
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

The purpose of this research study is to determine if video-based education will increase HPV vaccination rates among 11 - 17 year olds.

Detailed Description

Human Papillomavirus (HPV) is a common sexually transmitted infection that has the potential to cause cancer. The vaccine is recommended because it prevents the HPV infections that most commonly cause cancer. HPV vaccines offer the best protection to girls and boys who receive the complete, three-vaccine series and have time to develop an immune response before being exposed to HPV. However, vaccination rates are low compared to other vaccines for teens. Results from this study will help us learn why participants do or do not get the HPV vaccination and whether video-based education can help improve vaccination rates

Registry
clinicaltrials.gov
Start Date
July 2014
End Date
May 31, 2018
Last Updated
7 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Parent-child dyads in which the child is a male or female age 11 to 17 years who has not received the HPV vaccine

Exclusion Criteria

  • Parent-child dyads in which the child has received the HPV vaccine
  • Parent-child dyads in which the child is older than 18 at the time of enrollment
  • Non-English speakers

Outcomes

Primary Outcomes

HPV Vaccine Series Initiation

Time Frame: 0 days

HPV Vaccine Receipt among study participants

HPV Vaccination Series Initiation

Time Frame: 90 days

Number of HPV vaccine doses received among study participants

Secondary Outcomes

  • HPV Vaccine Series Initiation (depending on male versus female narrator)(90 days)

Study Sites (2)

Loading locations...

Similar Trials